Synbio International Inc. is pleased to announce the appointment of Ms. Desiree Cain, CPA, MBA as Chief Financial Officer and Member of the Board of Directors. This appointment reflects Synbio’s ongoing commitment to strengthening corporate governance and enhancing financial strategy to support its next phase of growth.
Health Technology Insights: QuantHealth Gains Sanofi Ventures Investment for AI Trials
Ms. Cain is a licensed Certified Public Accountant in the State of New York and holds an MBA in Strategic Management. With over 25 years of experience in corporate finance, accounting, and strategic growth management, she brings a proven track record in building financial infrastructure, optimizing operations, and driving shareholder value.
Health Technology Insights: Humana’s 2026 Medicare Advantage Plans Focus on Quality Care
As Chief Financial Officer, Ms. Cain will oversee all financial operations, including accounting, reporting, and compliance with U.S. SEC and OTC Markets requirements. She will lead the development of governance and risk management frameworks to align Synbio with best practices for public companies, ensuring transparency, accountability, and operational efficiency.
Health Technology Insights: InteropKey and Corista Unite for Value-Based Care Growth
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobeNewswire
